The theme underscores the significance of technological evolution in today's health systems. In this context, HTA is crucial for guiding health decision-making. The program enables discussions of both the opportunities and challenges that arise throughout the life cycle of new technologies, including evaluation methods, regulatory challenges, and economic impacts.

REBRATS is essential for the evaluation of new technologies within the SUS, having 117 Health Technology Assessment Units (NATS) distributed across all regions of the country and more than 900 members. The network's work ensures that technological innovations are rigorously assessed, guaranteeing that Brazilians have access to effective, safe, and cost-effective treatments. REBRATS' comprehensive and integrated approach strengthens HTA in Brazil and contributes to more informed and evidence-based health decisions.

In its fifth edition, the Meeting of REBRATS represents an important milestone in the history of HTA in Brazil. The event has become a key platform for presenting national scientific research, discussing public policies supported by HTA, and fostering collaboration among researchers, healthcare professionals, and HTA enthusiasts.

With an innovative program, we expect the 5th Meeting of REBRATS will provide another valuable opportunity for learning, collaboration, and advancing our mission to improve public health.